It means that a potential risk has been identified that was not previously known, and the magnitude of that risk has not yet been determined
The information presented in this activity is not meant to serve as a guideline for patient management
This combination of increased absorption and decreased metabolic efficiency creates a compounding effect that extends how long THC remains detectable in your body
Deep Dive: The GLP-1 Impact Background: Starting Tirzepatide (April 2024) In April 2024, I started Tirzepatide (Mounjaro/Zepbound) at 2.5mg, gradually escalating to 10mg over several months
In clinical trials, participants on the highest dose lost an average of 20.9% of their body weight
Participants randomized to retatrutide initiated treatment with 2 mg once weekly and increased the dose in a stepwise approach every four weeks until reaching the target dose of 4 mg (via steps at 2 mg and 4 mg), 9 mg (via steps at 2 mg, 4 mg, and 6 mg) or 12 mg (via steps at 2 mg, 4 mg, 6 mg, and 9 mg)